Free Trial

BNP Paribas Financial Markets Acquires Shares of 345,307 agilon health, inc. (NYSE:AGL)

agilon health logo with Medical background

BNP Paribas Financial Markets purchased a new position in shares of agilon health, inc. (NYSE:AGL - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 345,307 shares of the company's stock, valued at approximately $656,000. BNP Paribas Financial Markets owned approximately 0.08% of agilon health as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the stock. Ameriprise Financial Inc. acquired a new position in agilon health during the fourth quarter worth $79,000. Algert Global LLC lifted its holdings in agilon health by 1,042.7% in the fourth quarter. Algert Global LLC now owns 2,108,687 shares of the company's stock valued at $4,007,000 after buying an additional 1,924,157 shares during the period. Voleon Capital Management LP acquired a new stake in agilon health in the 4th quarter valued at $888,000. Schonfeld Strategic Advisors LLC raised its holdings in shares of agilon health by 102.1% in the 4th quarter. Schonfeld Strategic Advisors LLC now owns 88,503 shares of the company's stock worth $168,000 after acquiring an additional 44,703 shares during the last quarter. Finally, Northern Trust Corp grew its position in agilon health by 13.0% in the 4th quarter. Northern Trust Corp now owns 2,962,350 shares of the company's stock worth $5,628,000 after purchasing an additional 340,304 shares in the last quarter.

Analysts Set New Price Targets

Several brokerages have commented on AGL. Citigroup raised shares of agilon health from a "neutral" rating to a "buy" rating and raised their price target for the company from $3.25 to $5.00 in a report on Friday, April 25th. Needham & Company LLC reiterated a "hold" rating on shares of agilon health in a report on Friday, March 21st. Robert W. Baird decreased their price target on shares of agilon health from $6.00 to $5.00 and set a "neutral" rating on the stock in a research report on Tuesday, April 15th. Barclays raised their target price on shares of agilon health from $2.00 to $3.00 and gave the company an "underweight" rating in a research note on Thursday, May 8th. Finally, TD Cowen lifted their price target on shares of agilon health from $3.50 to $6.00 and gave the stock a "hold" rating in a research note on Tuesday, April 15th. Two equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating and five have given a buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Hold" and a consensus target price of $4.79.

Get Our Latest Stock Analysis on AGL

agilon health Stock Up 2.2%

Shares of AGL traded up $0.05 during mid-day trading on Wednesday, hitting $2.28. 623,860 shares of the company's stock were exchanged, compared to its average volume of 4,933,493. The firm has a fifty day moving average of $3.92 and a two-hundred day moving average of $3.18. agilon health, inc. has a twelve month low of $1.50 and a twelve month high of $7.73. The stock has a market cap of $943.40 million, a price-to-earnings ratio of -2.42 and a beta of 0.38. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06.

agilon health (NYSE:AGL - Get Free Report) last issued its quarterly earnings results on Tuesday, May 6th. The company reported $0.03 earnings per share for the quarter, beating analysts' consensus estimates of ($0.01) by $0.04. The firm had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.50 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The business's revenue was down 4.5% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.02) EPS. On average, sell-side analysts forecast that agilon health, inc. will post -0.59 earnings per share for the current year.

agilon health Profile

(Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Further Reading

Institutional Ownership by Quarter for agilon health (NYSE:AGL)

Should You Invest $1,000 in agilon health Right Now?

Before you consider agilon health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.

While agilon health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings Preview: HUGE Stock Move Ahead
These 5 Small Stocks Could Deliver Huge Returns
ACT FAST! Congress Is POURING Into This Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines